
A wellness app has launched new features that enable women to use their test data to help track reproductive hormones, manage their fertility windows, understand their cycles and make informed reproductive choices.
The features provide rapid results and digitised data to check hormone, hydration, and inflammation levels using at-home urine tests.
Results are displayed via the app within seconds of urination. The app uses deep learning image processing technology to analyse the test data which is then presented in a calendar allowing users to easily see precise ovulation and fertility windows.
The three tests on the the app – called Vivoo – measure either follicle-stimulating hormone (FSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). Elevated levels of these hormones within urine indicate ovulation is due (FSH and LH), or early stages of pregnancy (hCG).
Miray Tayfun, co-founder and CEO of Vivoo, commented: “As a team consisting of over 70 per cent women in our early 30s, the development of Vivoo’s reproductive hormone tests is deeply personal to us.
“We designed these tests in response to the real challenges we as individuals faced with regard to our reproductive health. Fertility is a growing global crisis, and during the development, many of us uncovered critical insights, some even made the life-changing decision to freeze their eggs.
“The trio of tests are vital tools to help women truly understand their bodies—pinpointing ovulation, tracking cycles, and providing actionable insights about fertility and vaginal health.
“Our mission is to empower women to make confident, informed choices, whether planning for children, choosing not to, or simply seeking a deeper connection with their health. Vivoo is here to support every step of their journeys.”
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









